Clinical Trial Update: Expression & Epigenetic Silencing of MicroRNA for Predicting Therapeutic Response and Prognosis of HPV-negative HNSCC

View source ↗

Summary

The clinical trial studied expression and epigenetic silencing of a microRNA as predictors of therapeutic response and prognosis in HPV-negative head and neck s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Head and Neck Squamous Cell Carcinoma | Status: COMPLETED